These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32387489)

  • 1. Dose-volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2020 Aug; 149():142-149. PubMed ID: 32387489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer.
    Rao SD; Saleh ZH; Setton J; Tam M; McBride SM; Riaz N; Deasy JO; Lee NY
    Acta Oncol; 2016; 55(1):99-104. PubMed ID: 25920361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT).
    Owosho AA; Pedreira Ramalho LM; Rosenberg HI; Yom SK; Drill E; Riedel E; Tsai CJ; Lee NY; Huryn JM; Estilo CL
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1408-13. PubMed ID: 27377999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center.
    Cardoso RC; Kamal M; Zaveri J; Chambers MS; Gunn GB; Fuller CD; Lai SY; Mott FE; McMillan H; Hutcheson KA
    Support Care Cancer; 2021 Apr; 29(4):1825-1835. PubMed ID: 32779007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Rates of Radiation-induced Trismus and Lowered Mastication Structure Doses in Patients Treated for Head and Neck Cancer During the Last Two Decades.
    Pettersson N; Andersson E; Pauli N; Tuomi L; Finizia C; Olsson CE
    Clin Oncol (R Coll Radiol); 2024 Oct; 36(10):e388-e397. PubMed ID: 39095285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients.
    Gebre-Medhin M; Haghanegi M; Robért L; Kjellén E; Nilsson P
    Acta Oncol; 2016 Nov; 55(11):1313-1317. PubMed ID: 27595312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
    Kamal M; Mohamed ASR; Volpe S; Zaveri J; Barrow MP; Gunn GB; Lai SY; Ferrarotto R; Lewin JS; Rosenthal DI; Jethanandani A; Meheissen MAM; Mulder SL; Cardenas CE; Fuller CD; Hutcheson KA;
    Radiother Oncol; 2018 Sep; 128(3):442-451. PubMed ID: 29961581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-based Data Mining to Probe Dosimetric Correlates of Radiation-induced Trismus.
    Beasley W; Thor M; McWilliam A; Green A; Mackay R; Slevin N; Olsson C; Pettersson N; Finizia C; Estilo C; Riaz N; Lee NY; Deasy JO; van Herk M
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1330-1338. PubMed ID: 30061005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up.
    Chen YY; Zhao C; Wang J; Ma HL; Lai SZ; Liu Y; Han F; Lu LX; Bao Y; Chen M
    Cancer; 2011 Jul; 117(13):2910-6. PubMed ID: 21264821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Hamming-Vrieze O; Verheijen S; Lamers E; van der Molen L; Hilgers FJ; van den Brekel MW; Heemsbergen WD
    Head Neck; 2019 May; 41(5):1387-1394. PubMed ID: 30652390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2017 Aug; 124(2):232-239. PubMed ID: 28733053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismus.
    Hague C; Beasley W; Garcez K; Lee LW; McPartlin A; McWilliam A; Ryder D; Sykes AJ; Thomson D; van Herk M; West C; Slevin NJ
    Acta Oncol; 2018 Aug; 57(8):1038-1042. PubMed ID: 29630433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus.
    Teguh DN; Levendag PC; Voet P; van der Est H; Noever I; de Kruijf W; van Rooij P; Schmitz PI; Heijmen BJ
    Head Neck; 2008 May; 30(5):622-30. PubMed ID: 18213726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.
    van der Molen L; Heemsbergen WD; de Jong R; van Rossum MA; Smeele LE; Rasch CR; Hilgers FJ
    Radiother Oncol; 2013 Mar; 106(3):364-9. PubMed ID: 23540551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral complications of head and neck radiotherapy: prevalence and management.
    Germano F; Melone P; Testi D; Arcuri L; Marmiroli L; Petrone A; Arcuri C
    Minerva Stomatol; 2015 Aug; 64(4):189-202. PubMed ID: 25937580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
    Cao J; Zhang X; Jiang B; Chen J; Wang X; Wang L; Sahoo N; Zhu XR; Ye R; Blanchard P; Garden AS; Fuller CD; Gunn GB; Frank SJ
    Radiother Oncol; 2021 Jul; 160():32-39. PubMed ID: 33839202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
    Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
    Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Oskam IM; van der Molen L; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Oral Oncol; 2015 Aug; 51(8):787-94. PubMed ID: 26027851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.